| Impact of conditioning intensity of allogeneic transplantation for acute myeloid leukemia with genomic evidence of residual disease CS Hourigan, LW Dillon, G Gui, BR Logan, M Fei, J Ghannam, Y Li, ... Journal of Clinical Oncology 38 (12), 1273, 2020 | 335 | 2020 |
| Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc … J Bolaños-Meade, R Reshef, R Fraser, M Fei, S Abhyankar, Z Al-Kadhimi, ... The Lancet Haematology 6 (3), e132-e143, 2019 | 233 | 2019 |
| Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM). P Hari, MC Pasquini, EA Stadtmauer, R Fraser, M Fei, SM Devine, ... Journal of Clinical Oncology 38 (15_suppl), 8506-8506, 2020 | 85 | 2020 |
| Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report JR Schriber, PN Hari, KW Ahn, M Fei, LJ Costa, MA Kharfan‐Dabaja, ... Cancer 123 (16), 3141-3149, 2017 | 79 | 2017 |
| Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes—long-term follow-up of … BL Scott, MC Pasquini, M Fei, R Fraser, J Wu, SM Devine, DL Porter, ... Transplantation and cellular therapy 27 (6), 483. e1-483. e6, 2021 | 74 | 2021 |
| Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902) WA Wood, J Le‐Rademacher, KL Syrjala, H Jim, PB Jacobsen, JM Knight, ... Cancer 122 (1), 91-98, 2016 | 71 | 2016 |
| Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host … M Hamadani, MJ Zhang, XY Tang, M Fei, C Brunstein, S Chhabra, ... Biology of Blood and Marrow Transplantation 26 (7), 1312-1317, 2020 | 56 | 2020 |
| Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis A Mahindra, P Hari, R Fraser, M Fei, J Huang, J Berdeja, N Callander, ... Bone marrow transplantation 52 (12), 1616-1622, 2017 | 53 | 2017 |
| Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF–mobilized stem cell transplantation EK Waller, BR Logan, M Fei, SJ Lee, D Confer, A Howard, ... Blood Advances 3 (15), 2250-2263, 2019 | 46 | 2019 |
| Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia JN Barker, M Fei, C Karanes, M Horwitz, S Devine, TL Kindwall‐Keller, ... British journal of haematology 168 (3), 405-412, 2015 | 45 | 2015 |
| Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia M Eapen, MJ Zhang, XY Tang, SJ Lee, MW Fei, H Wang, KM Hebert, ... Biology of Blood and Marrow Transplantation 26 (7), e161-e166, 2020 | 42 | 2020 |
| Speciation of phosphorus in a fertilized, reduced‐till soil system: In‐field treatment incubation study R Khatiwada, GM Hettiarachchi, DB Mengel, M Fei Soil Science Society of America Journal 76 (6), 2006-2018, 2012 | 42 | 2012 |
| Autologous/allogeneic hematopoietic cell transplantation versus tandem autologous transplantation for multiple myeloma: comparison of long-term postrelapse survival M Htut, A D'Souza, A Krishnan, B Bruno, MJ Zhang, M Fei, MA Diaz, ... Biology of Blood and Marrow Transplantation 24 (3), 478-485, 2018 | 38 | 2018 |
| Tandem autologous-autologous versus autologous-allogeneic hematopoietic stem cell transplant for patients with multiple myeloma: long-term follow-up results from the Blood and … S Giralt, LJ Costa, D Maloney, A Krishnan, M Fei, JH Antin, C Brunstein, ... Biology of Blood and Marrow Transplantation 26 (4), 798-804, 2020 | 37 | 2020 |
| Outcomes of measurable residual disease in pediatric acute myeloid leukemia before and after hematopoietic stem cell transplant: validation of difference from normal flow … DA Jacobsohn, MR Loken, M Fei, A Adams, LE Brodersen, BR Logan, ... Biology of Blood and Marrow Transplantation 24 (10), 2040-2046, 2018 | 37 | 2018 |
| Umbilical cord blood transplantation in children with acute leukemia: impact of conditioning on transplantation outcomes M Eapen, J Kurtzberg, MJ Zhang, G Hattersely, M Fei, A Mendizabal, ... Biology of Blood and Marrow Transplantation 23 (10), 1714-1721, 2017 | 33 | 2017 |
| Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine AC Harris, JJ Boelens, KW Ahn, M Fei, A Abraham, A Artz, C Dvorak, ... Blood advances 2 (11), 1198-1206, 2018 | 31 | 2018 |
| Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes after hematopoietic stem cell transplantation: a study from the Blood and Marrow … JM Knight, KL Syrjala, NS Majhail, M Martens, J Le-Rademacher, ... Biology of Blood and Marrow Transplantation 22 (12), 2256-2263, 2016 | 31 | 2016 |
| Minimal residual disease (MRD) assessment before and after autologous hematopoietic cell transplantation (AutoHCT) and maintenance for multiple myeloma (MM): results of the … TE Hahn, PK Wallace, R Fraser, M Fei, JD Tario, A Howard, Y Zhang, ... Biology of Blood and Marrow Transplantation 25 (3), S4-S6, 2019 | 27 | 2019 |
| Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702/07LT) A Dispenzieri, A Krishnan, B Arendt, B Blackwell, PK Wallace, S Dasari, ... Blood cancer journal 12 (2), 27, 2022 | 23 | 2022 |
Ganga HettiarachchiProfessor of Soil and Environmental Chemistry, Kansas State UniversityVerifierad e-postadress på ksu.edu
